These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2594870)

  • 1. Haloperidol and reduced haloperidol plasma levels in Chinese vs. non-Chinese psychiatric patients.
    Jann MW; Chang WH; Davis CM; Chen TY; Deng HC; Lung FW; Ereshefsky L; Saklad SR; Richards AL
    Psychiatry Res; 1989 Oct; 30(1):45-52. PubMed ID: 2594870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of haloperidol and reduced haloperidol plasma levels in four different ethnic populations.
    Jann MW; Chang WH; Lam YW; Hwu HG; Lin HN; Chen H; Chen TY; Lin SK; Chien CP; Davis CM
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Mar; 16(2):193-202. PubMed ID: 1579637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextromethorphan phenotyping and haloperidol disposition in schizophrenic patients.
    Lane HY; Hu OY; Jann MW; Deng HC; Lin HN; Chang WH
    Psychiatry Res; 1997 Mar; 69(2-3):105-11. PubMed ID: 9109178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients.
    Lin KM; Poland RE; Nuccio I; Matsuda K; Hathuc N; Su TP; Fu P
    Am J Psychiatry; 1989 Oct; 146(10):1307-11. PubMed ID: 2782476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
    Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia.
    Rao VA; Bishop M; Coppen A
    Br J Psychiatry; 1980 Dec; 137():518-21. PubMed ID: 7214106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethnic comparison of haloperidol and reduced haloperidol plasma levels: Taiwan Chinese versus American non-Chinese.
    Chang WH; Jann MW; Hwu HG; Chen TY; Lin SK; Wang JM; Ereshefsky L; Saklad SR; Richards AL; Lam YW
    J Formos Med Assoc; 1991 Jun; 90(6):572-8. PubMed ID: 1681004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced haloperidol does not interfere with the antipsychotic activity of haloperidol in the treatment of acute schizophrenia.
    Ulrich S; Neuhof S; Braun V; Meyer FP
    Int Clin Psychopharmacol; 1999 Jul; 14(4):219-28. PubMed ID: 10468314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study.
    McEvoy JP; Stiller RL; Farr R
    J Clin Psychopharmacol; 1986 Jun; 6(3):133-8. PubMed ID: 3711363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol.
    Altamura AC; Buccio M; Colacurcio F; Colombo G; Terzi A
    Acta Neurol (Napoli); 1986 Feb; 8(1):19-26. PubMed ID: 3962752
    [No Abstract]   [Full Text] [Related]  

  • 11. Haloperidol concentrations elevated in Chinese patients.
    Potkin SG; Shen Y; Pardes H; Phelps BH; Zhou D; Shu L; Korpi E; Wyatt RJ
    Psychiatry Res; 1984 Jun; 12(2):167-72. PubMed ID: 6591221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent reduced haloperidol/haloperidol ratios in schizophrenic patients.
    Chang WH; Hwu HG; Lane HY; Lin SK; Chen TY; Chen H; Wei HL; Lin WL; Lin HN
    Psychiatry Res; 1991 Sep; 38(3):215-25. PubMed ID: 1754634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of plasma concentrations of haloperidol after the addition of fluoxetine.
    Goff DC; Midha KK; Brotman AW; Waites M; Baldessarini RJ
    Am J Psychiatry; 1991 Jun; 148(6):790-2. PubMed ID: 2035723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood levels of reduced haloperidol versus clinical efficacy and extrapyramidal side effects of haloperidol.
    Lane HY; Lin HN; Hu OY; Chen CC; Jann MW; Chang WH
    Prog Neuropsychopharmacol Biol Psychiatry; 1997 Feb; 21(2):299-311. PubMed ID: 9061775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of smoking on haloperidol and reduced haloperidol plasma concentrations and haloperidol clearance.
    Jann MW; Saklad SR; Ereshefsky L; Richards AL; Harrington CA; Davis CM
    Psychopharmacology (Berl); 1986; 90(4):468-70. PubMed ID: 3101102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra- and interethnic variability in reduced haloperidol to haloperidol ratios.
    Lam YW; Jann MW; Chang WH; Yu HS; Lin SK; Chen H; Davis CM
    J Clin Pharmacol; 1995 Feb; 35(2):128-36. PubMed ID: 7751421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.
    Wright P; Lindborg SR; Birkett M; Meehan K; Jones B; Alaka K; Ferchland-Howe I; Pickard A; Taylor CC; Roth J; Battaglia J; Bitter I; Chouinard G; Morris PL; Breier A
    Can J Psychiatry; 2003 Dec; 48(11):716-21. PubMed ID: 14733451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects].
    Schilkrut R; Haverbeck C; Duran E; Delgado S; Kohen P; Birkner R; Katz I
    Acta Psiquiatr Psicol Am Lat; 1981; 27(4-5):315-24. PubMed ID: 7348089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes.
    Krakowski M; Czobor P; Volavka J
    Psychiatry Res; 1997 Jun; 71(1):19-26. PubMed ID: 9247978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.
    Tran PV; Dellva MA; Tollefson GD; Beasley CM; Potvin JH; Kiesler GM
    J Clin Psychiatry; 1997 May; 58(5):205-11. PubMed ID: 9184614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.